Agency: Cordis | Branch: FP7 | Program: CP | Phase: ENV.2012.6.5-1 | Award Amount: 4.74M | Year: 2012
In the marine environment, anthropogenic pressures on resources and non-anthropogenic causes may create harmful conditions that affect human society. Harmful algal blooms and habitat destruction are examples, which pose serious human-health threats and severely affect numerous industries, causing annual economic losses in the tens of millions of euros, in the form of reduced sales, diminished tourist activity and unemployment. A widely adopted, scientific way to assess the environmental status of water bodies is by measuring their optical properties (as indicators of, e.g., sewage impact, dissolved organic matter, sediment load or gross biological activity). The Citclops project aims to develop systems to retrieve and use data on seawater colour, transparency and fluorescence, using low-cost sensors combined with contextual information (e.g., georeferencing) and a community-based Internet platform, taking into account existing experiences (e.g., Secchi Dip-In, Coastwatch Europe and Oil Reporter). Simple and fast methods to establish the optical properties of seawater will be developed and used: e.g., the colour through Forel-Ule observations, and transparency through a variant of the Secchi disc. People will be able to acquire data taking photographs of the sea surface on ferries or other vessels, at the open sea or from the beach. Wearable digital cameras for aquatic activities with extended sensing systems are also proposed as alternative resources for crowdsourcing data. Data are automatically uploaded through a specific service or application (such as Google\ Instant Upload), archived remotely and processed, and resulting information is accessed through a webpage or a mobile application by end users. These are: policy makers (e.g., local administrations), which will be able to use the information to improve the management of the coastal zone; and citizens, who will be able to maximize their experience in activities in which water quality has a role.
Agency: Cordis | Branch: FP7 | Program: CPCSA | Phase: ICT-2011.5.3 | Award Amount: 3.55M | Year: 2012
The overarching objective of the DECIPHER Project is to enable secure cross-border mobile access to existing patient healthcare portals which are individually supported by national (governmental) bodies. DECIPHER will deploy Pre-commercial Procurement (PCP) to create step-change innovations in mobile patient ICTs. Using electronic patient records as the key enabling technology, this joint PCP will create technology-led service transformation in cross-border mobile healthcare, delivering significant benefits to patients and healthcare organisations. The Consortium consists of three leading commissioning authorities: ESTAV Centro (Italy), TicSalut (Spain/Catalonia) and CMFT (UK). A single, joint PCP activity will be issued. Suppliers will be challenged to build on outputs from epSOS, CALLIOPE, and LOD2, and advances in mobile technology. Experts from Greece, France, Finland, UK, Sweden and Ireland will provide support.
DECIPHER will generate a portfolio of interoperable applications, deployed on a pan-European platform. This resource will improve existing healthcare services by supporting mobility of patients and healthcare providers. From anywhere in the EU, a patient will be able to use a secure mobile device safely to gain 24/7 access to their prescription data, emergency data, examination results and other health information. To take this opportunity forward, the Consortium has put in place a well-defined Programme Plan. When implemented, the plan will: 1) mobilise the Consortium partners; 2) engage citizens, healthcare professionals, and industry; 3) leverage currently unconnected assets to create new and transformational innovations; 4) deliver step-change improvements to public services; and, 5) contribute to job and wealth creation in Europe. A detailed Dissemination Plan is in place to ensure key stakeholders (e.g. industry, PCP policy and commissioning authorities) are informed and encouraged to engage with DECIPHER.
***************************************************************Project periods and milestones are updated taking as a fact that the project suspension duration is 12 months***************************************************************
Barcelona Digital and la Caixa | Date: 2010-12-28
A system and a method for determining the reliability of blacklists is disclosed. Each blacklist comprises IP addresses of supposedly infected computers. The reliability is computed by analyzing whether the blacklist reports or not controlled infections from sandboxed environments and by measuring the elapsed time between reported infections and disinfections. The obtained information is then used in combination with several metrics for determining the trustworthiness of the IP address of a given Internet host that requests an online transaction with the purpose of granting or denying access to a service.
Agency: Cordis | Branch: FP7 | Program: CSA | Phase: ICT-2013.5.3 | Award Amount: 1.03M | Year: 2013
Brain-computer interfaces (BCIs) have become a popular topic for research in recent years. A BCI is a communication device which allows people to control applications through direct measures of their brain activity. A BNCI (brain/neuronal computer interaction) system extends a BCI by including other physiological measures such as muscle or eye movement signals.\nThe number of BCI research groups around the world, peer-reviewed journal articles, conference abstracts, and attendance at relevant conferences are indicators of the rapid growth of this field. With dozens of companies and research groups actively participating in the development of BCIs and related technologies, collaboration, a common terminology, and a clear roadmap have become important topics. To provide a solution to these issues, the European Commission (EC) funded the coordination action Future BNCI in 2010/2011. This project, led by TUG, was the first effort to foster collaboration and communication among key stakeholders.\nThis proposal, BNCI Horizon 2020, aims to continue and improve upon the efforts initiated by Future BNCI. Our consortium includes eight major European BCI research institutions, three industrial partners, and two end user organizations (one of which is also a research partner).\nA main result of BNCI Horizon 2020 will be a clear and concise roadmap to support the EC in their funding decisions for the new framework program Horizon 2020. More specifically, we will focus on consolidating recent results in BNCI research and on investigating new BNCI activities and synergies with relevant fields. We will discuss potential new applications leading to the enhancement of functions for people with motor, sensory, cognitive and mental disabilities. Furthermore, we will elaborate on key technological advancements necessary to achieve future goals, and we will touch upon other key topics including ethics, societal needs for and acceptance of BNCI systems, user-centered approaches, evaluation metrics, and the transfer of technology from research labs to the market.\nBNCI Horizon 2020 will foster communication, collaboration, and dissemination of information; create public awareness of BNCIs by organizing a retreat-style conference specifically for companies and end users; create and maintain a website for researchers, reviewers, the industry, end users, and the general public; and involve both academic and industrial key stakeholders as well as end users and end user associations.\nAll these areas are important to further advance this still young and growing research field into a full-fledged major research discipline. A clear and comprehensive roadmap produced by BNCI Horizon 2020 will lay the foundations for, and impact on, a (continued) dominance and clear visibility of European research groups in the future. In addition, the roadmap will display opportunities, but also limitations and constraints, for the industrialization and commercialization of BNCIs.
Agency: Cordis | Branch: FP7 | Program: CP | Phase: ICT-2011.5.5 | Award Amount: 4.19M | Year: 2012
Research efforts have improved Brain-Neural Computer Interface (BNCI) technology in many ways and numerous applications have been prototyped. Until recently, these BNCI systems have been researched almost exclusively in laboratories. Home usage has been demonstrated, though only with on-going expert supervision. A significant advance on BNCI research and its implementation as a feasible assistive technology is therefore the migration of BNCIs into peoples homes to provide new options for communication and control that increase independence and reduce social exclusion. The goal of BackHome is to move BNCIs from laboratory devices for healthy users toward practical devices used at home by people in need. This implies a system which is easy to set up, portable, and straightforward. Thus, BackHome will (1) develop BNCI systems into practical multimodal assistive technologies that will provide useful solutions for communication, web-surfing, and environmental control, and (2) provide this technology for home usage with minimal support. These goals will be attained through three key developments: practical electrodes; telemonitoring with home software support; and easy-to-use applications tailored to peoples needs. BackHome will build on on-going projects in the FP7 BNCI cluster that laid the foundations for this project and provide us with a network of connections and resources that will be valuable in the project. The consortium combines extensive experience with software development, definition of standards, neuroscience and psychology research methods, user-centred approaches and training users in their homes. We will leverage this experience to get BackHome started quickly, maintain solid interactions with end users, and interact effectively with other key research groups. We will evaluate, disseminate and plan future exploitation of the BackHome scientific and technical results in close interaction with end-users. BackHome will thus have a strong impact on European dominance in the field, in the short and longer term, and could make a real difference not only for the end-users targeted but also for caregivers, support personnel, and medical professionals.